Go to deals
Agriculture | TMT

Archisen focuses on urban farming

Archisen Pte Ltd. has completed a fundraising.

Archisen is a Singapore-based startup company that designs, develops and operates systems and solutions to grow ultra-fresh, ultra-local produce in urban cities. The company designs modular urban farm systems comprising of commercial off-the-shelf and readily available components from their solution partners. Their turn-key solution consists of site acquisition, site survey, crop selection, farm design, sale of produce, obtaining approvals from the authorities as well as financial modelling for profitable returns. Archisen has developed Croptron™, a smart urban farming system that uses sensors, IoT technology and data analytics to improve farm management processes and crop yields by monitoring parameters such as microclimate data, plant physiology, soil and water conditions in real time.

Oaklins’ team in Singapore acted as introductory agent in this transaction.

Talk to the deal team

Gerald Ong

Partner
Singapore, Singapore
Oaklins PrimePartners

Related deals

Bharal Développement (Difagri) has acquired Dietagro
Agriculture

Bharal Développement (Difagri) has acquired Dietagro

Bharal Développement Group, comprising the Difagri and Alinova brands, has acquired Dietagro as part of its build-up strategy to expand its industrial capabilities and further diversify its expertise across animal species and dosage forms.

Learn more
SRT Marine has completed a placing and subscription
TMT

SRT Marine has completed a placing and subscription

SRT Marine Systems plc has announced an equity raise of at least US$22 million at US$1.10 per share representing a 5.75% discount, through a US$19.4 million accelerated bookbuild placing and a US$2 million subscription by Ocean Infinity, alongside a separate retail offer of up to US$1.3 million.

Learn more
IXICO has completed a fundraising
Healthcare

IXICO has completed a fundraising

IXICO plc, a specialist in AI-driven neuroimaging analytics, has completed a US$13.5 million gross capital raise. The funds will be used to support the company’s tech bio strategy, which will see IXICO partner its platform to maximize its potential.

Learn more